143 related articles for article (PubMed ID: 35491201)
1. Association between Green Tea Consumption and In-Stent Restenosis in a Chinese Population after Percutaneous Coronary Intervention.
Zhang J; Ma Y; Wang Z; Li Y; Wang H; Wang Q
J Nutr Sci Vitaminol (Tokyo); 2022; 68(2):120-126. PubMed ID: 35491201
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.
Li M; Hou J; Gu X; Weng R; Zhong Z; Liu S
Eur J Med Res; 2022 Jan; 27(1):12. PubMed ID: 35065663
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
Zeng M; Yan X; Wu W
BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
[TBL] [Abstract][Full Text] [Related]
5. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
Wang P; Qiao H; Wang R; Hou R; Guo J
BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
[TBL] [Abstract][Full Text] [Related]
6. Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation: CTRP5 promoting inflammation, migration and proliferation in vascular smooth muscle cells.
Shen Y; Li C; Zhang RY; Zhang Q; Shen WF; Ding FH; Lu L
Int J Cardiol; 2017 Feb; 228():129-136. PubMed ID: 27863353
[TBL] [Abstract][Full Text] [Related]
7. Resistant in-stent restenosis in the drug eluting stent era.
Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
[TBL] [Abstract][Full Text] [Related]
8. Association of serum apoA-I with in-stent restenosis in coronary heart disease.
Wang X; Zhang M; Cheng J; Zhou H
BMC Cardiovasc Disord; 2022 Aug; 22(1):355. PubMed ID: 35927634
[TBL] [Abstract][Full Text] [Related]
9. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
Chen T; Sun JL; Zhang J
Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study.
Zhang L; Wang Y; Zhang Z; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
BMC Cardiovasc Disord; 2021 Sep; 21(1):438. PubMed ID: 34525967
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
Almalla M; Pross V; Marx N; Hoffmann R
Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
[TBL] [Abstract][Full Text] [Related]
13. Predictor of in-stent restenosis in patients with drug-eluting stent (PRIDE)- a retrospective cohort study.
Gupta PK; Balachander J
Clin Investig Arterioscler; 2021; 33(4):184-194. PubMed ID: 33622608
[TBL] [Abstract][Full Text] [Related]
14. Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study.
Xie F; Yu Z; Xiong Y; Wu Z; Wu Y
Eur J Med Res; 2024 Feb; 29(1):145. PubMed ID: 38409069
[TBL] [Abstract][Full Text] [Related]
15. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
[TBL] [Abstract][Full Text] [Related]
16. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
[TBL] [Abstract][Full Text] [Related]
17. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
Zhao L; Zhu W; Zhang X; He D; Guo C
BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study.
Redfors B; Généreux P; Witzenbichler B; Maehara A; Weisz G; McAndrew T; Mehran R; Kirtane AJ; Stone GW
Am Heart J; 2018 Mar; 197():142-149. PubMed ID: 29447774
[TBL] [Abstract][Full Text] [Related]
19. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
20. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S
Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]